JP Morgan Chase’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-60
| Closed | -$82 | – | 7055 |
|
|
2025
Q1 | $82 | Sell |
60
-5
| -8% | -$7 | ﹤0.01% | 6903 |
|
|
2024
Q4 | $103 | Sell |
65
-2
| -3% | -$3 | ﹤0.01% | 7002 |
|
|
2024
Q3 | $83 | Hold |
67
| – | – | ﹤0.01% | 7029 |
|
|
2024
Q2 | $90 | Sell |
67
-3
| -4% | -$4 | ﹤0.01% | 6909 |
|
|
2024
Q1 | $95 | Sell |
70
-753
| -91% | -$1.6K | ﹤0.01% | 6912 |
|
|
2023
Q4 | $2.16K | Sell |
823
-157,039
| -99% | -$380K | ﹤0.01% | 6711 |
|
|
2023
Q3 | $505K | Sell |
157,862
-6,155
| -4% | -$28.7K | ﹤0.01% | 4470 |
|
|
2023
Q2 | $825K | Sell |
164,017
-278,077
| -63% | -$1.41M | ﹤0.01% | 4195 |
|
|
2023
Q1 | $1.27M | Buy |
442,094
+134,835
| +44% | +$394K | ﹤0.01% | 3869 |
|
|
2022
Q4 | $719K | Buy |
307,259
+237,621
| +341% | +$725K | ﹤0.01% | 4279 |
|
|
2022
Q3 | $313K | Sell |
69,638
-13,438
| -16% | -$96.2K | ﹤0.01% | 4731 |
|
|
2022
Q2 | $487K | Sell |
83,076
-75,356
| -48% | -$387K | ﹤0.01% | 4584 |
|
|
2022
Q1 | $1.03M | Sell |
158,432
-25,235
| -14% | -$249K | ﹤0.01% | 4237 |
|
|
2021
Q4 | $2.35M | Sell |
183,667
-1,178
| -0.6% | -$16.5K | ﹤0.01% | 3731 |
|
|
2021
Q3 | $2.56M | Sell |
184,845
-57,487
| -24% | -$605K | ﹤0.01% | 3580 |
|
|
2021
Q2 | $2.5M | Sell |
242,332
-574,290
| -70% | -$5.69M | ﹤0.01% | 3631 |
|
|
2021
Q1 | $7.89M | Buy |
816,622
+175,242
| +27% | +$1.75M | ﹤0.01% | 2578 |
|
|
2020
Q4 | $4.62M | Buy |
641,380
+34,817
| +6% | +$231K | ﹤0.01% | 2872 |
|
|
2020
Q3 | $2.85M | Sell |
606,563
-48,959
| -7% | -$242K | ﹤0.01% | 2989 |
|
|
2020
Q2 | $3.64M | Buy |
655,522
+537,084
| +453% | +$2.23M | ﹤0.01% | 2698 |
|
|
2020
Q1 | $425K | Buy |
118,438
+107,456
| +978% | +$721K | ﹤0.01% | 3892 |
|
|
2019
Q4 | $93K | Sell |
10,982
-40,103
| -79% | -$290K | ﹤0.01% | 4927 |
|
|
2019
Q3 | $346K | Buy |
51,085
+7,035
| +16% | +$49.9K | ﹤0.01% | 4351 |
|
|
2019
Q2 | $264K | Sell |
44,050
-129,371
| -75% | -$703K | ﹤0.01% | 4549 |
|
|
2019
Q1 | $1.09M | Buy |
173,421
+101,366
| +141% | +$784K | ﹤0.01% | 3749 |
|
|
2018
Q4 | $467K | Sell |
72,055
-51,009
| -41% | -$309K | ﹤0.01% | 4161 |
|
|
2018
Q3 | $874K | Buy |
123,064
+32,228
| +35% | +$179K | ﹤0.01% | 3993 |
|
|
2018
Q2 | $395K | Buy |
90,836
+72,736
| +402% | +$268K | ﹤0.01% | 4280 |
|
|
2018
Q1 | $54K | Buy |
+18,100
| New | +$46.6K | ﹤0.01% | 4788 |
|
|
2017
Q4 | – | Sell |
-1,996
| Closed | -$7K | – | 5418 |
|
|
2017
Q3 | $7K | Buy |
+1,996
| New | +$5.15K | ﹤0.01% | 4762 |
|
Other funds holding APYX
NCM
ACM
RA
SBCM
HKAM
TFCM
